Ceo And Director
CurrentAscendant Biotech is assembling a portfolio of first-in-man technologies (diagnostics and therapeutics) to be delivered via its Treatment Access Platform. Portfolio addresses chronic and terminal diseases and includes viral therapeutics, neoantigen vaccines, cancer diagnostics, neurodegenerative disease diagnostics, and regenerative medicine.